Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial.

Elizabeth A Thiele E Martina BebinFrancis FillouxPatrick KwanRachael LoftusFarhad SahebkarSteven SparaganaJames W Wheless

Published in: Epilepsia (2021)

In patients with TSC, long-term add-on CBD treatment was well tolerated and sustainably reduced seizures through 48 weeks, with most patients/caregivers reporting global improvement.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
clinical trial
palliative care
peritoneal dialysis
combination therapy
preterm birth